Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Mears Group acquires Care UK’s domiciliary care service for £11.3m

Support services firm Mears Group has bought Care UK’s home care division, as was first reported by HealthInvestor, for a sum of £11.3 million.

The purchase price comprises of a base payment of £9 million with a further payment of £2.3 million made in respect of cash balances and excess working capital acquired on completion.

Care UK’s home care service looks after approximately 13,000 people across the UK and employs around 6,000 staff members.

For the year ended 30 September 2014, it reported revenues of £72.2 million and an operating loss before exceptional items of £2.6 million.

In a statement, Mears said Care UK had already started closing some branches of the domiciliary care business because of “particularly poor results in certain regions”.

The acquired assets will be renamed Mears Care and the management team will remain the same.

David Miles, chief executive of Mears Group (pictured), said: "I believe we have acquired one of our most significant competitors at an attractive valuation. Our focus will be upon enhancing service delivery thus enabling financial improvements.”

The acquisition  marks the completion of Care UK’s divestment strategy, which also saw it sell off its mental health and learning disability divisions. The private care provider has said it plans focus solely primary and secondary NHS health services and residential and nursing homes.

In May, Care UK sold its mental health assets, comprising of 322 beds, to Partnerships in Care for an undisclosed sum. It also sold its learning disability services group to Lifeways in the same month.

According to a press release, the three transactions, which had a combined annual ebitda of £12.9 million last year, have generated £130 million (before fees and expenses) for Care UK.

Mike Parish, chief executive of Care UK, said: “We are pleased to have reached very positive outcomes for patients and services users, colleagues and commissioners in all three services. The strategic review process which is now completed strengthens Care UK’s positioning for future growth within both the health and social care sectors.”

Rothschild advised Care UK on its divestments.


Related articles:

Posted on: 01/06/2015

Latest news stories

22/05/2019
Cygnet Health Care is under regulatory scrutiny after a BBC Panorama undercover documentary exposed evidence of “sickening” patient abuse at a hospital for people with autism and learning disabilities
22/05/2019
A new report commissioned by AgeUK reveals the extent of the “local lottery” for residential and home care in England, observing that “care deserts” are emerging in some areas.
21/05/2019
Healthcare real estate investment trust Assura has reported an increase in profits and revenues as a result of portfolio growth in its full-year results for the 12 months ended 31 March 2019.
21/05/2019
UK skincare specialist group sk:n has acquired Destination Skin, a chain of 16 aesthetic skincare clinics, with ambitious plans to open new clinics under both brands in the coming months.
21/05/2019
There have been 77 transactions in the global IVF and fertility market since 2009, with M&A activity peaking in 2018, finds new analysis.


Civica


HealthInvestor blog
As the self-pay care home market booms, the state-funded sector is under increasing pressure to survive. The government must act to ensure a dignified and secure future for all our older citizens

Click here to view the HealthInvestor blog


An electronics engineer, applying technology to break down the limits of care, improve patient outcomes and change lives for the better… Also, named on the Sunday Times Maserati 100, its annual list of entrepreneurs
James Allen joined the National Care Group as chief executive in April, but new to the post doesn’t mean new to the sector. With a fresh pair of eyes, he discusses provision and trends in the adult social care sector with Marie Cahalane
Horizon chief executive Paul Callander talks to Marie Cahalane about children’s services and analyses funding and provision – as we eagerly await the social care Green Paper
The UK medicinal cannabis sector is becoming mainstream as a result of changes to the law, a growing body of scientific research and evolving social attitudes. While not without its challenges and risks, it already offers a range of opportunities for investors that are likely to increase over time. Catherine Gooderham asks, where do the investment opportunities lie?
The European care market remains active, the result of growing demand, well-entrenched multiples, and the potential for growth through pan-European expansion. Marie Cahalane considers market opportunities and examines the prospects for UK operators

Click here to search all feature articles



Something new...

We've entered the era of the app - there seems to be one for everything and health is no different. Gus Booth-Clibborn, co-founder and chief executive of Tomo, talks mental health and 'appiness with Marie Cahalane
Read more


Christie + Co

my images



Care homes
While the self-pay care and nursing home market is seeing record levels of investment, the UK state-pay system is on its knees with operators struggling to survive as local government payments fall well below the true cost of care. Rob Munro reports on the crisis engulfing a market worth nearly £16 billion a year
Read more